Remineralization Efficacy of Gum Arabic Varnish.

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Unknown
Phase 3
Phase 2

Conditions

Remineralization
Caries,Dental
White Spot Lesion

Treatments

Drug: MI Varnish,GC Japan Inc.
Drug: Proflourid Varnish,VOCO
Drug: Gum Arabic varnish

Study type

Interventional

Funder types

Other

Identifiers

NCT04422860
CEBD-2

Details and patient eligibility

About

The aim of this study is to evaluate the remineralizing capacity of Gum Arabic varnish and its implementation into clinical practice.

Enrollment

90 estimated patients

Sex

All

Ages

17 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with initial carious lesions.
  • Proper Oral hygiene.

Exclusion criteria

  • Patients with a compromised medical history.
  • Patients with active severe periodontal disease.
  • Patients with hypoplastic or hypomineralized teeth.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 3 patient groups

Gum Arabic varnish
Experimental group
Description:
Gum arabic (Acacia senegal) is an exudate obtained from Acacia senegal stems and roots, and other similar African Acacia species. It consists mainly of high molecular weight polysaccharides high concentrations of calcium, magnesium, and potassium salts which can potentially increase tooth remineralization.
Treatment:
Drug: Gum Arabic varnish
Sodium Fluoride varnish
Active Comparator group
Description:
The gold standard remineralizing agent recommended by the guidelines.
Treatment:
Drug: Proflourid Varnish,VOCO
10% w/v CPP-ACP, 5% sodium fluoride varnish
Active Comparator group
Description:
CPP-ACP is the most studied non fluoride remineralizing agent.
Treatment:
Drug: MI Varnish,GC Japan Inc.

Trial contacts and locations

1

Loading...

Central trial contact

Rawda H. A.ElAziz, Post Phd; Ahmed H. Samaha, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems